High dose toremifene as a cisplatin modulator: Targeted plasma levels are achievable clinically

被引：0
|
作者：
Gandara, DR
Lara, P
Cadman, T
Lau, D
Uhrich, M
Turrell, C
Morgan, R
Dimery, I
Edelman, M
Perez, EA
Synold, T
Doroshow, J
Muggia, F
DeGregorio, M
机构：
[1] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA
[2] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[3] Univ So Calif, Los Angeles, CA 90089 USA
[4] Mayo Clin, Jacksonville, FL 32224 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 1998年 / 46卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：148A / 148A
页数：1
相关论文
共 50 条
  • [1] High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically
    Lara, PN
    Gandara, DR
    Wurz, GT
    Lau, D
    Uhrich, M
    Turrell, C
    Raschko, J
    Edelman, MJ
    Synold, T
    Doroshow, J
    Muggia, F
    Perez, EA
    DeGregorio, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (06) : 504 - 508
  • [2] High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically
    Primo N. Lara Jr.
    David R. Gandara
    Gregory T. Wurz
    Derick Lau
    Margaret Uhrich
    Corinne Turrell
    James Raschko
    Martin J. Edelman
    Timothy Synold
    James Doroshow
    Franco Muggia
    Edith A. Perez
    Mike DeGregorio
    Cancer Chemotherapy and Pharmacology, 1998, 42 : 504 - 508
  • [3] PLASMA PLATINUM LEVELS - RELATIONSHIP TO CISPLATIN DOSE AND NEPHROTOXICITY
    CAMPBELL, AB
    KALMAN, SM
    JACOBS, C
    CANCER TREATMENT REPORTS, 1983, 67 (02): : 169 - 172
  • [4] The effect of treatment with high dose melphalan, cisplatin or carboplatin on levels of glutathione in plasma, erythrocytes, mononuclear cells and urine
    Hogarth, L
    English, M
    Price, L
    Wyllie, R
    Pearson, ADJ
    Hall, AG
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 37 (05) : 479 - 485
  • [5] A COMPARISON OF 2 DOSE LEVELS OF GRANISETRON IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN
    SOUKOP, M
    EUROPEAN JOURNAL OF CANCER, 1990, 26 : S15 - S19
  • [6] CHANGES IN SERUM IRON LEVELS FOLLOWING VERY HIGH-DOSE CISPLATIN
    POLLERA, CF
    AMEGLIO, F
    REINA, S
    NARDI, M
    ABBOLITO, MR
    PARRACINO, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 19 (03) : 257 - 260
  • [7] PLASMA LEVELS OF LIDOCAINE FOLLOWING HIGH DOSE INTRAMUSCULAR ADMINISTRATION
    ZENER, JC
    SPIVACK, AP
    HARRISON, DC
    KERBER, RE
    CIRCULATION, 1972, 46 (04) : 239 - +
  • [8] Low proportion of pre-treatment estrogen receptor (ER) positivity in patients enrolled in a phase II trial of high dose toremifene as a cisplatin
    Lara, PN
    Mack, PC
    Gumerlock, PH
    Gandara, DR
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (02) : 99A - 99A
  • [9] HIGH-DOSE CISPLATIN TREATMENT - HEARING-LOSS AND PLASMA-CONCENTRATIONS
    LAURELL, G
    JUNGNELIUS, U
    LARYNGOSCOPE, 1990, 100 (07): : 724 - 734
  • [10] VARIABILITY OF PLASMA-LEVELS OF METHOTREXATE DURING HIGH DOSE THERAPY
    NELSEN, MA
    BLUM, MR
    LOEFFLER, LJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 193 - 193
12345